Feature | May 08, 2013

Launch of Multicenter RELIEF Registry to Collect Data on MR-Guided Focused Ultrasound Treatment for Uterine Fibroids

Focused Ultrasound Foundation, Philips and InSightec collaborate with leading clinicians and support the establishment of the international multicenter RELIEF registry

The Focused Ultrasound Foundation, Royal Philips Electronics and InSightec Ltd today announced that they are collaborating with leading clinicians in the field and support the establishment of a multicenter registry to evaluate MR-guided focused ultrasound treatment for uterine fibroids (also known as uterine leiomyomas).  

The international registry, titled RELIEF (REgistry for Leiomyoma: International Efficacy of Focused Ultrasound) will start in the second half of 2013. Over a three-year period, the registry will collect data from 1,000 women treated with focused ultrasound. The resulting database is intended to provide large scale evidence on safety, efficacy and long-term durability of this novel treatment for uterine fibroids to facilitate reimbursement and drive rapid physician acceptance. More than 30 leading treatment sites will participate in the studies. Furthermore, all active MR-guided focused ultrasound sites are welcome to participate.

The announcement was made at a symposium today on the Future of Fibroid Treatment hosted by the Focused Ultrasound Foundation's patient education program Fibroid Relief.

"MR-guided focused ultrasound is a new and completely non-invasive, uterine-preserving treatment alternative to hysterectomy," said initiator of the study and principal investigator Jaron Rabinovici, M.D., vice chairman of the department of obstetrics and gynecology, Sheba Medical Center, Israel. "It is our hope that the RELIEF registry will help to accelerate the adoption of this option by providing additional evidence to assure payers that the treatment is not only effective in the short-term, but also a long-term solution for women seeking relief from their fibroid symptoms."

Rabinovici continued: "Each year, there are thousands of women who could benefit from this low risk procedure, but who are currently forced to select a more invasive alternative out of concern that their insurer will not pay for the treatment. In today's healthcare environment, payers have higher thresholds for novel technologies which can severely limit widespread acceptance and access. RELIEF should provide the data that will help payers to make their decisions."

The primary and secondary outcomes of RELIEF will include quality of life, necessity of additional treatments, adverse events, satisfaction with the treatment, and time to return to work/normal activities. Additional measures will include medical resource utilization post-treatment, pregnancy, general health-related quality of life, and the association between fibroid treatment volume, age, baseline symptoms, fibroid characteristics and clinical outcome. The patients will be screened and expected to complete scheduled follow-up at intervals of 1 and 6 months and 1, 2, and 3 years after treatment. Registry data from key milestones and the final analysis will be submitted for publication.

The RELIEF registry Steering Committee oversees the design, monitoring and follow-up of the registry. Dr. Rabinovici leads the Steering Committee of global focused ultrasound experts that includes Anne Roberts, M.D. (University of California, San Diego); Elizabeth A. Stewart, M.D. (Mayo Clinic, Rochester, Minn.); Robert K. Zurawin, M.D. (Baylor College of Medicine, Houston); Elizabeth David, MD (Sunnybrook Health Sciences Centre, Toronto, Canada); Wladyslaw M. Gedroyc, M.D. (St. Mary's Hospital, London, UK); Young-Sun Kim, M.D. (Samsung Medical Center, Seoul, South Korea); Matthias Matzko, M.D. (Amper Kliniken, Dachau, Germany); and Harsh Rastogi, M.D. (Indraprastha Apollo Hospital, New Delhi, India).

The RELIEF registry will be conducted through Fibroid Relief, with regulatory oversight and operational management in collaboration with KAI Research, Inc. 

For more information: www.fusfoundation.org, www.philips.com/newscenter, us.insightec.com

 

Related Content

Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Carestream Launches MR Brain Perfusion and Diffusion Modules for Vue PACS
Technology | Advanced Visualization | August 16, 2017
Carestream Health recently introduced new MR (magnetic resonance) Brain Perfusion and MR Brain Diffusion modules that...
ISMRM Issues Guidelines for MRI Gadolinium Contrast Agents
News | Contrast Media | August 15, 2017
The International Society for Magnetic Resonance in Medicine (ISMRM) has provided new guidance in the use of contrast...
MRI Reveals Striking Brain Differences in People with Genetic Autism

Example images for a control participant , a deletion carrier, and a duplication carrier. In the sagittal image of the deletion carrier, the thick corpus callosum, dens and craniocervical abnormality, and cerebellar ectopia are shown. For the duplication carrier, the sagittal image shows the thin corpus callosum and the axial image shows the increased ventricle size and decreased white matter volume. Image courtesy of the Radiological Society of North America (RSNA).

News | Neuro Imaging | August 09, 2017
August 9, 2017 — In the first major study of its kind, researchers using magnetic...
GE Healthcare's Signa Premier MRI Receives FDA 510(k) Clearance
Technology | Magnetic Resonance Imaging (MRI) | August 04, 2017
GE Healthcare announced Signa Premier, a new wide bore 3.0T magnetic resonance imaging (MRI) system, is now available...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
brain with chronic traumatic injury
News | Magnetic Resonance Imaging (MRI) | August 02, 2017
Fighters are exposed to repeated mild traumatic brain injury (mTBI), which has been associated with neurodegenerative...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Overlay Init